Αποτελέσματα Αναζήτησης
4 Απρ 2024 · During labor and delivery, this drug is utilized after delivery to assist involution and decrease hemorrhage. Under full obstetric supervision, this drug may be given in the second stage of labor following delivery of the anterior shoulder. There are no controlled data in human pregnancy.
Methylergonovine maleate (Methergine) is an ergot alkaloid that produces sustained contraction of the uterus via stimulation of myometrial α-adrenergic receptors. From: Clinics in Perinatology, 2008
Methylergonovine injection is used to prevent and control bleeding from the uterus that can happen after childbirth. It belongs to the class of medicines called ergot alkaloids. This medicine works by acting directly on the smooth muscles of the uterus and prevents bleeding after giving birth.
10 Φεβ 2020 · Methylergonovine is intended for use after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium; use is contraindicated during pregnancy. Methylergonovine is recommended when a supplemental uterotonic agent is needed; due to maternal side effects it is not preferred for initial use (ACOG 183 2017).
Pregnant or trying to get pregnant. Breast-feeding. How should I use this medication? This medication is injected into a muscle or into a vein. It is given in a hospital or clinic setting. Talk to your care team about the use of this medication in children. Special care may be needed.
This medication must not be used during pregnancy. It may harm an unborn baby. Consult your doctor for more details. This medication may decrease the amount of breast milk.
Medscape - Postpartum hemorrhage dosing for Methergine (methylergonovine), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.
